The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Axcella Health Inc COM 05454B105 36,504 7,901,362 SH   DFND 2,3 0 7,901,362 0
Axcella Health Inc COM 05454B105 21,469 4,647,052 SH   DFND 3 0 4,647,052 0
Denali Therapeutics Inc COM 24823R105 214,273 5,980,263 SH   DFND 1,3 0 5,980,263 0
Evelo Biosciences Inc COM 299734103 24,436 4,636,785 SH   DFND 2,3 0 4,636,785 0
Evelo Biosciences Inc COM 299734103 53,782 10,205,282 SH   DFND 1,3 0 10,205,282 0
Evelo Biosciences Inc COM 299734103 42,466 8,058,002 SH   DFND 3 0 8,058,002 0
Kaleido Biosciences Inc COM 483347100 108,043 9,759,979 SH   DFND 1,3 0 9,759,979 0
Kaleido Biosciences Inc COM 483347100 18,339 1,656,643 SH   DFND 2,3 0 1,656,643 0
Kaleido Biosciences Inc COM 483347100 87,941 7,944,088 SH   DFND 3 0 7,944,088 0
Moderna Inc COM 60770K107 2,183,883 30,867,600 SH   DFND 2,3 0 30,867,600 0
Moderna Inc COM 60770K107 278 3,924 SH   DFND 3 0 3,924 0
Rubius Therapeutics Inc COM 78116T103 58,010 11,578,828 SH   DFND 1,3 0 11,578,828 0
Rubius Therapeutics Inc COM 78116T103 121,012 24,153,995 SH   DFND 2,3 0 24,153,995 0
Rubius Therapeutics Inc COM 78116T103 12,844 2,563,703 SH   DFND 3 0 2,563,703 0
Seres Therapeutics Inc COM 81750R102 359,052 12,682,876 SH   DFND 2,3 0 12,682,876 0
Seres Therapeutics Inc COM 81750R102 251,644 8,888,888 SH   DFND 3 0 8,888,888 0
Syros Pharmaceuticals Inc COM 87184Q107 25,976 2,938,494 SH   DFND 2,3 0 2,938,494 0